We are live on ! Find out more

17 hedge funds and large institutions have $2.85M invested in Myomo in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.13% less ownership

Funds ownership: 26.3%25.16% (-1.1%)

8% less capital invested

Capital invested by funds: $3.09M → $2.85M (-$234K)

19% less funds holding

Funds holding: 2117 (-4)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
4
Closed
5
Calls
Puts
Net Calls
Net Calls Change

MYO Hedge Fund Activity: Q3 2022 in Review

17 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q3 2022, worth a combined $2.85M — down 7.6% from $3.09M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MYO and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $28.8K. The largest seller was Vanguard Group, cutting an estimated $69.2K.

  • 17 institutional investors held Myomo (MYO) as of Q3 2022, down from 21 in Q2 2022.
  • Funds reported $2.85M of Myomo stock for Q3 2022, down 7.6% quarter-over-quarter.
  • 1 fund opened new Myomo positions in Q3 2022 and 5 closed out, a net change of -4 holders.
  • The largest Myomo buyer in Q3 2022 was Renaissance Technologies, an estimated $28.8K added.
  • The largest Myomo seller in Q3 2022 was Vanguard Group, an estimated $69.2K sold.

Based on aggregated 13F filings for Q3 2022.